Tirzepatide is an advanced dual-agonist peptide that simultaneously targets GLP-1 and GIP receptors.

Engineered for metabolic enhancement, it is highly popular for fat loss, appetite suppression, and maximizing calorie expenditure.

✅ Triggers fat loss via dual-receptor metabolic activation
✅ Appetite suppression and prolonged satiety
✅ Promotes fat oxidation while preserving lean muscle mass

Clinical Properties and Mechanisms:
▪️ Metabolic Impact: By binding to receptors for glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), the substance influences the body’s glucose regulation and energy balance.
▪️ Appetite Regulation: Studies indicate that the mechanism of action includes signaling to the brain that can affect feelings of satiety.

Administration and Protocols
▪️ Administration Method: Subcutaneous injection is the primary method for Tirzepatide administration.
▪️ Administration Frequency:Protocols involve weekly administrations to maintain stable levels, as indicated in various research studies.
▪️ Protocol Duration: Common research protocols last between four to sixteen weeks based on your target goals.